Aqueous zinc-bromine microbatteries (Zn-Br MBs) are promising energy storage devices for miniaturized electronic applications. However, their performance in low-temperature environments remains a challenge due to poor compatibility between antifreeze agents and complexing agents. In this work, we propose an additive-free electrolyte design to address this incompatibility from the source. An electrochemically active 7.5 m zinc bromide solution was found to have a low freezing point of -105 °C, while also inhibiting polybromide dissolution. Zn-Br microbatteries using this electrochemically active electrolyte demonstrated excellent cycling stability, with over 10,000 cycles (99% capacity retention) at 25 °C and more than 2000 cycles (98% capacity retention) at -60 °C. Both experimental data and theoretical calculations demonstrate that low-temperature environments inhibit polybromide dissolution. This work addresses the issue of incompatibility between antifreeze and complexing agents, challenging the traditional reliance on organic complexing agents to prevent polybromide dissolution in Zn-Br systems.

Download full-text PDF

Source
http://dx.doi.org/10.1021/acsnano.5c00988DOI Listing

Publication Analysis

Top Keywords

complexing agents
12
polybromide dissolution
12
zinc-bromine microbatteries
8
additive-free electrolyte
8
electrolyte design
8
low-temperature environments
8
electrochemically active
8
dissolution zn-br
8
capacity retention
8
enabling low-temperature
4

Similar Publications

Uveitis involves a complex interplay of immune cell infiltration and cytokine imbalances, with Th17 cells playing a central role in this process. Th17 cells contribute to disease pathogenesis by promoting inflammation, recruiting additional immune cells, and directly damaging retinal tissues. This review discusses the current knowledge on therapeutic strategies targeting Th17-related cytokines, including cytokine blockade, small molecule inhibitors, and immunomodulatory approaches.

View Article and Find Full Text PDF

Revumenib: First Approval.

Drugs

March 2025

Springer Nature, Mairangi Bay, Private Bag 65901, Auckland, 0754, New Zealand.

Revumenib (Revuforj) is an oral, first-in-class menin inhibitor developed by Syndax Pharmaceuticals for the treatment of KMT2A-rearranged (KMT2Ar) acute leukaemia, NPM1-mutated (NPM1m) acute myeloid leukaemia (AML) and solid tumours. The interaction between menin and the KMT2A protein complex leads to aberrant gene expression, driving leukaemogenic transcription. By blocking this interaction, revumenib promotes differentiation and exerts antileukaemic activity in KMT2Ar acute leukaemias and other menin inhibition-sensitive leukaemias.

View Article and Find Full Text PDF

Digital subtraction angiography (DSA) is the gold standard for assessing cerebrovascular hemodynamics. DSA is predominantly utilized to evaluate the hemodynamic information of various cerebral diseases. However, DSA is relatively invasive and involves radiation exposure and risks of allergic reactions or renal dysfunction related to iodine-based contrast agents.

View Article and Find Full Text PDF

Introduction: Leukocytoclastic vasculitis (LCV) is a small-vessel inflammatory condition that can rarely occur as an adverse drug reaction (ADR). Vancomycin-induced LCV is an uncommon but potentially serious complication, particularly in patients with pre-existing renal impairment.

Reason For The Report: This case report describes a patient with end-stage renal disease (ESRD) who developed LCV following vancomycin therapy for a catheter-related infection.

View Article and Find Full Text PDF

Impacts of Naphthenic Acids (NAs) Exposure on Soil Bacterial Community and Antibiotic Resistance Genes (ARGs) Dissemination.

Curr Microbiol

March 2025

Key Laboratory of Plant Biotechnology of Liaoning Province, School of Life Sciences, Liaoning Normal University, Dalian, 116081, China.

Naphthenic acids (NAs) are indigenous and complex components in petroleum. In the context of increasing global energy demand, the increasing extraction of fossil resources leads to increased environmental release of NAs, resulting in various environmental risks. However, the impact of NAs exposure on soil microorganisms remains still unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!